Clinical Trials List
Protocol NumberBAP00307
Not yet recruiting
2005-10-01 - 2006-10-01
Phase III
Terminated3
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 何承懋 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 湯宏仁 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
770 participants
